{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,27]],"date-time":"2026-02-27T04:23:03Z","timestamp":1772166183578,"version":"3.50.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T00:00:00Z","timestamp":1763510400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100010795","name":"Chugai Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010795","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Thrombosis J"],"DOI":"10.1186\/s12959-025-00798-6","type":"journal-article","created":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:42:48Z","timestamp":1763545368000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Infrared thermography for detecting compensatory load in people with haemophilia: a cross-sectional study"],"prefix":"10.1186","volume":"23","author":[{"given":"Yuya","family":"Mawarikado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asuka","family":"Sakata","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Midori","family":"Shima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chihiro","family":"Hosoda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naoki","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryohei","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenichi","family":"Ogiwara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shoko","family":"Furukawa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naruto","family":"Shimonishi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuhiro","family":"Soeda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohei","family":"Tatsumi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yusuke","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Akira","family":"Kido","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keiji","family":"Nogami","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,11,19]]},"reference":[{"issue":"9371","key":"798_CR1","doi-asserted-by":"publisher","first-page":"1801","DOI":"10.1016\/S0140-6736(03)13405-8","volume":"361","author":"PH Bolton-Maggs","year":"2003","unstructured":"Bolton-Maggs PH, Pasi KJ. Haemophilias A and B. Lancet. 2003;361(9371):1801\u20139.","journal-title":"Lancet"},{"issue":"Suppl 6","key":"798_CR2","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/hae.14046","volume":"26","author":"A Srivastava","year":"2020","unstructured":"Srivastava A, et al. WFH guidelines for the management of hemophilia, 3rd edition. Haemophilia. 2020;26(Suppl 6):1\u2013158.","journal-title":"Haemophilia"},{"issue":"7","key":"798_CR3","doi-asserted-by":"publisher","first-page":"63","DOI":"10.3390\/jcm6070063","volume":"6","author":"D Melchiorre","year":"2017","unstructured":"Melchiorre D, Manetti M, Matucci-Cerinic M. Pathophysiology of hemophilic arthropathy. J Clin Med. 2017;6(7):63.","journal-title":"J Clin Med"},{"issue":"Suppl 4","key":"798_CR4","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1111\/j.1365-2516.2008.01732.x","volume":"14","author":"FP Lafeber","year":"2008","unstructured":"Lafeber FP, Miossec P, Valentino LA. Physiopathology of haemophilic arthropathy. Haemophilia. 2008;14(Suppl 4):3\u20139.","journal-title":"Haemophilia"},{"issue":"5","key":"798_CR5","first-page":"3883","volume":"16","author":"T Zhang","year":"2018","unstructured":"Zhang T, et al. Clinical outcomes of arthroscopic synovectomy for adolescent or young adult patients with advanced haemophilic arthropathy. Exp Ther Med. 2018;16(5):3883\u20138.","journal-title":"Exp Ther Med"},{"issue":"2","key":"798_CR6","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/hae.13383","volume":"24","author":"SJ Song","year":"2018","unstructured":"Song SJ, et al. Mid-term outcomes and complications of total knee arthroplasty in haemophilic arthropathy: a review of consecutive 131 knees between 2006 and 2015 in a single Institute. Haemophilia. 2018;24(2):299\u2013306.","journal-title":"Haemophilia"},{"issue":"8","key":"798_CR7","doi-asserted-by":"publisher","first-page":"937","DOI":"10.1177\/1071100720929002","volume":"41","author":"J Ahn","year":"2020","unstructured":"Ahn J, Yoo MC, Seo J, Park M, Jeong BO. Comparison of total ankle arthroplasty and ankle arthrodesis in end-stage hemophilic arthropathy. Foot Ankle Int. 2020;41(8):937\u201344.","journal-title":"Foot Ankle Int"},{"issue":"6","key":"798_CR8","first-page":"1223","volume":"5","author":"M Sillero-Quintana","year":"2015","unstructured":"Sillero-Quintana M, et al. Infrared thermography as a support tool for screening and early diagnosis in emergencies. J Med Imaging Health Inf. 2015;5(6):1223\u20138.","journal-title":"J Med Imaging Health Inf"},{"key":"798_CR9","first-page":"51","volume":"18","author":"J Selfe","year":"2008","unstructured":"Selfe J, Whitaker J, Hardaker N. A narrative literature review identifying the minimum clinically important difference for skin temperature asymmetry at the knee. Thermol Int. 2008;18:51\u20134.","journal-title":"Thermol Int"},{"issue":"1","key":"798_CR10","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s12959-023-00511-5","volume":"21","author":"R Kawasaki","year":"2023","unstructured":"Kawasaki R, et al. The use of infrared thermography for non-invasive detection of bleeding and musculoskeletal abnormalities in patients with hemophilia: an observational study. Thromb J. 2023;21(1):70.","journal-title":"Thromb J"},{"issue":"8","key":"798_CR11","doi-asserted-by":"publisher","first-page":"1222","DOI":"10.1123\/jsr.2019-0056","volume":"29","author":"P G\u00f3mez-Carmona","year":"2020","unstructured":"G\u00f3mez-Carmona P, Fern\u00e1ndez-Cuevas I, Sillero-Quintana M, Arnaiz-Lastras J, Navandar A. Infrared thermography protocol on reducing the incidence of soccer injuries. J Sport Rehabil. 2020;29(8):1222\u20137.","journal-title":"J Sport Rehabil"},{"key":"798_CR12","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.infrared.2015.02.007","volume":"71","author":"I Fern\u00e1ndez-Cuevas","year":"2015","unstructured":"Fern\u00e1ndez-Cuevas I, et al. Classification of factors influencing the use of infrared thermography in humans: a review. Infrared Phys Technol. 2015;71:28\u201355.","journal-title":"Infrared Phys Technol"},{"issue":"7","key":"798_CR13","doi-asserted-by":"publisher","first-page":"834","DOI":"10.1123\/jsr.2022-0390","volume":"32","author":"T Castonguay","year":"2023","unstructured":"Castonguay T, Dover G. Infrared thermography-a novel tool for monitoring fracture healing: a critically appraised topic with evidence-based recommendations for clinical practice. J Sport Rehabil. 2023;32(7):834\u20139.","journal-title":"J Sport Rehabil"},{"issue":"4","key":"798_CR14","doi-asserted-by":"publisher","first-page":"283","DOI":"10.3340\/jkns.2015.57.4.283","volume":"57","author":"YS Lee","year":"2015","unstructured":"Lee YS, et al. The effectiveness of infrared thermography in patients with whiplash injury. J Korean Neurosurg Soc. 2015;57(4):283\u20138.","journal-title":"J Korean Neurosurg Soc"},{"key":"798_CR15","doi-asserted-by":"publisher","first-page":"103187","DOI":"10.1016\/j.jtherbio.2022.103187","volume":"104","author":"PV Alburquerque Santana","year":"2022","unstructured":"Alburquerque Santana PV, et al. Relationship between infrared thermography and muscle damage markers in physically active men after plyometric exercise. J Therm Biol. 2022;104:103187.","journal-title":"J Therm Biol"},{"issue":"7","key":"798_CR16","doi-asserted-by":"publisher","first-page":"e0132367","DOI":"10.1371\/journal.pone.0132367","volume":"10","author":"K Ashina","year":"2015","unstructured":"Ashina K, et al. Histamine induces vascular hyperpermeability by increasing blood flow and endothelial barrier disruption in vivo. PLoS ONE. 2015;10(7):e0132367.","journal-title":"PLoS ONE"},{"issue":"4","key":"798_CR17","doi-asserted-by":"publisher","first-page":"485","DOI":"10.3109\/17453677308989084","volume":"44","author":"MF Hauge","year":"1973","unstructured":"Hauge MF. The knee in patients with hip joint ankylosis. Clinical survey and bio-mechanical aspects. Acta Orthop Scand. 1973;44(4):485\u201395.","journal-title":"Acta Orthop Scand"},{"issue":"11","key":"798_CR18","doi-asserted-by":"publisher","first-page":"1689","DOI":"10.2522\/ptj.20150597","volume":"96","author":"N Poquet","year":"2016","unstructured":"Poquet N, Williams M, Bennell K. Exercise for osteoarthritis of the hip. Phys Ther. 2016;96(11):1689\u201394.","journal-title":"Phys Ther"},{"issue":"1","key":"798_CR19","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1186\/s12891-023-06235-x","volume":"24","author":"KL Paterson","year":"2023","unstructured":"Paterson KL, et al. Shoes for self-managing chronic hip pain: the SCHIPP randomized clinical trial protocol. BMC Musculoskelet Disord. 2023;24(1):141.","journal-title":"BMC Musculoskelet Disord"},{"issue":"7","key":"798_CR20","doi-asserted-by":"publisher","first-page":"1125","DOI":"10.1136\/annrheumdis-2012-202745","volume":"72","author":"L Fernandes","year":"2013","unstructured":"Fernandes L, et al. EULAR recommendations for the non-pharmacological core management of hip and knee osteoarthritis. Ann Rheum Dis. 2013;72(7):1125\u201335.","journal-title":"Ann Rheum Dis"},{"issue":"10","key":"798_CR21","doi-asserted-by":"publisher","first-page":"2394","DOI":"10.1111\/jth.15424","volume":"19","author":"S Hassan","year":"2021","unstructured":"Hassan S, et al. Health and treatment outcomes of patients with hemophilia in the Netherlands, 1972\u20132019. J Thromb Haemost. 2021;19(10):2394\u2013406.","journal-title":"J Thromb Haemost"}],"container-title":["Thrombosis Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12959-025-00798-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12959-025-00798-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,19]],"date-time":"2025-11-19T09:42:49Z","timestamp":1763545369000},"score":1,"resource":{"primary":{"URL":"https:\/\/thrombosisjournal.biomedcentral.com\/articles\/10.1186\/s12959-025-00798-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11,19]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["798"],"URL":"https:\/\/doi.org\/10.1186\/s12959-025-00798-6","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-7042817\/v1","asserted-by":"object"}]},"ISSN":["1477-9560"],"issn-type":[{"value":"1477-9560","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11,19]]},"assertion":[{"value":"4 July 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 November 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All participants were given a clear and comprehensive explanation of the study on the basis of the Declaration of Helsinki. Subsequently, participants signed informed consent forms. Ethical approval for the studies was obtained from both the Nara Medical University (ID: 2097) and Chugai Ethics Committees (ID: E19086).","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval"}},{"value":"No identifiable subject information is provided in the manuscript, figures, or tables.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"YM, AS, MS, NM, RK, TS, KT, and KN are members of the Medicinal Biology of Thrombosis and Haemostasis established by Nara Medical University and Chugai Pharmaceutical Co., Ltd. NM, RK, and TS are employees of Chugai Pharmaceutical Co., Ltd. NM and RK have stock ownership of Chugai Pharmaceutical Co., Ltd. MS is a representative of the Medicinal Biology of Thrombosis and Haemostasis collaborative research laboratory; research support from Chugai Pharmaceutical Co., Ltd.; Takeda Pharmaceutical Co., Ltd.; and CSL Behring; received honoraria or consultation fees from Chugai Pharmaceutical Co., Ltd.; is a speaker for Chugai Pharmaceutical Co., Ltd.; and CSL Behring, Sanofi, Bayer, Novo Nordisk Pharma, Takeda Pharmaceutical Co., Ltd., Pfizer, and Fujimoto Seiyaku Corp.; and has patents for inventions relating to products of Chugai Pharmaceutical Co., Ltd.CH has no conflict of interest to decare. KO has received personal fees from Chugai Pharmaceutical Co., Ltd., and CSL Behring. SF taught a course endowed by CSL Behring and received personal fees from Chugai Pharmaceutical Co., Ltd., CSL Behring, Takeda Pharmaceutical Co., and Sanofi S.A.NS taught a course endowed by CSL Behring.KT received grants or research support from the Japan Blood Products Organization, The Mother and Child Health Foundation and Novo Nordisk Pharma. YI received specified clinical trial funding from MediaMart Co., Ltd.; research funding from Chugai Pharmaceutical Co., Ltd., Johnson & Johnson K.K., KM Biologics, Olympus Terumo Biomaterials Corp., and Zimmer Biomet; and honoraria from Asahi Kasei Pharma Corporation, Bayer Yakuhin Ltd., Chugai Pharmaceutical Co., Ltd., CSL Behring, Healious K.K., Hisamitsu Pharmaceutical Co., Johnson & Johnson K.K., Ono Pharmaceutical Co., Ltd., Novo Nordisk Pharma Ltd., Sanofi K.K., and Takeda Pharmaceutical Co., Ltd.; and is a medical advisor for Chugai Pharmaceutical Co., Ltd. and KM Biologics.AK received personal fees from Hisamitsu Pharmaceutical Co. and Tsumura & Co. KN received grants, personal fees, and nonfinancial support from Chugai Pharmaceutical Co., Ltd.; personal fees from Hoffmann-La Roche Ltd.; grants and personal fees from Sysmex Co., SEKISUI MEDICAL., Takeda Pharmaceutical Co., Sanofi S.A., Co., Ltd., CSL Behring Co., KM Biologics Co., Ltd., Novo Nordisk A\/S, Bayer AG, and Fujimoto Seiyaku; is an inventor of patents relating to emicizumab; and is a member of the Medicinal Biology of Thrombosis and Haemostasis established by Nara Medical University and Chugai Pharmaceutical Co., Ltd.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"112"}}